Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Kikoko's performance in the California market shows a mixed trajectory across different product categories. In the Beverage category, Kikoko has seen fluctuations, ranking 21st in both August and November 2025, with a brief improvement to 17th in October. This suggests some volatility in their Beverage sales, although they remain within the top 30 brands. In contrast, the Capsules category showcases a more stable and strong presence, consistently ranking within the top 4 positions from August through November, indicating a solid foothold in this segment. The Edible category presents a different picture, where Kikoko has not managed to break into the top 30, with rankings hovering in the low 40s. This could point to challenges in gaining traction in the Edible market segment.
Overall, Kikoko's performance in California demonstrates their strength in Capsules, maintaining a steady top 4 ranking, while their Beverage and Edible categories show room for growth. The fluctuations in the Beverage rankings may indicate seasonal or competitive pressures, but the consistent top-tier placement in Capsules suggests a loyal customer base or effective product differentiation. Meanwhile, the Edible category's absence from the top 30 could imply a need for strategic adjustments to enhance market penetration or product appeal. This analysis highlights the importance of category-specific strategies for Kikoko to maintain and improve its market position across different cannabis product segments.
Competitive Landscape
In the competitive landscape of the California capsules market, Kikoko has maintained a consistent presence, ranking 4th in August, October, and November 2025, with a brief rise to 3rd place in September. This fluctuation highlights a competitive pressure from brands like ABX / AbsoluteXtracts, which consistently held the 3rd position except in September when Kikoko briefly surpassed them. Despite this, Kikoko's sales trajectory shows a slight decline from August to November, contrasting with the steady performance of Breez, which maintained its 2nd rank throughout the period. While Buddies and Emerald Bay Extracts remained stable at 5th and 6th ranks respectively, Kikoko's ability to temporarily climb in rank suggests potential for strategic growth, though it faces challenges in sustaining sales momentum against its top competitors.

Notable Products
In November 2025, Kikoko's top-performing product was the XTabs - Indica High Dose Tablets 20-Pack (1000mg) in the Capsules category, maintaining its number one rank with sales of 3543 units. The XTabs - Sativa High Dose Tablets 20-Pack (1000mg) held steady at the second position, despite a slight decrease in sales. The XTabs - Hybrid High Dose Tablets 20-Pack (1000mg) consistently ranked third throughout the past months, showing stable performance. Little Helpers - CBN/THC/Melatonin 3:2 Sleep Mints 20-Pack remained in fourth place, with a modest increase in sales compared to October. The XTabs - THC/CBN/CBD Sleep Tablets 20-Pack also retained its fifth-place ranking, indicating consistent demand in the Capsules category.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







